Results 221 to 230 of about 47,199,121 (367)
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Exploring the Role of Advanced Practice Nurses in Cardiology: A Scoping Review. [PDF]
Sguanci M+7 more
europepmc +1 more source
Researches concerning the periodical meteors of August and November [PDF]
Sears C. Walker, A. D. Bache
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
Examining Foot Shape Variations in Individuals With and Without Diabetes. [PDF]
Hemler SL+4 more
europepmc +1 more source